Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma

Background/Aim: To evaluate the association between baseline [18F]FDG-PET/CT tumor burden parameters and disease progression rate after first-line target therapy or immunotherapy in advanced melanoma patients. Materials and Methods: Forty four melanoma patients, who underwent [18F]FDG-PET/CT before...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Virginia Liberini, Marco Rubatto, Riccardo Mimmo, Roberto Passera, Francesco Ceci, Paolo Fava, Luca Tonella, Giulia Polverari, Adriana Lesca, Marilena Bellò, Vincenzo Arena, Simone Ribero, Pietro Quaglino, Désirée Deandreis
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
immune checkpoint inhibitors
PD-1
PD-L1
CTLA-4
immunotherapy
target therapy
Medicine
R
Acceso en línea:https://doaj.org/article/066e395753a74684b6a1ceafa6566f8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/066e395753a74684b6a1ceafa6566f8f

Ejemplares similares